Reason for request
Inscription
Mise à disposition d'un biosimilaire de Lovenox.
Clinical Benefit
| Substantial |
le service médical rendu par INHIXA est important dans les indications de l’AMM. |
Clinical Added Value
| no clinical added value |
En tant que médicament biosimilaire, INHIXA n’apporte pas d’amélioration du service médical rendu (ASMR V) par rapport au médicament biologique de référence, LOVENOX. |
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
4K33p7Ynj9gzys7R
